Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
50,868,756
-
Total 13F shares
-
43,665,569
-
Share change
-
-657,924
-
Total reported value
-
$458,056,816
-
Put/Call ratio
-
77%
-
Price per share
-
$10.49
-
Number of holders
-
184
-
Value change
-
-$8,562,901
-
Number of buys
-
90
-
Number of sells
-
77
Institutional Holders of REGENXBIO Inc. - Common Stock (RGNX) as of Q3 2024
As of 30 Sep 2024,
REGENXBIO Inc. - Common Stock (RGNX) was held by
184 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
43,665,569 shares.
The largest 10 holders included
BlackRock, Inc., Redmile Group, LLC, VANGUARD GROUP INC, STATE STREET CORP, JPMORGAN CHASE & CO, MORGAN STANLEY, Integral Health Asset Management, LLC, DIMENSIONAL FUND ADVISORS LP, Avidity Partners Management LP, and Balyasny Asset Management L.P..
This page lists
184
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.